Also, expression of RANK and its ligand by prostate cancer cells promotes epithelial-to-mesenchymal transition and bone metastasis [170,171], indicating a potential for RANK targeting in prostate cancer. This evidence concerns the gene TNFRSF11A and prostate carcinoma.